Literature DB >> 24856227

Symptom burden in stable COPD patients with moderate or severe airflow limitation.

J Eckerblad1, K Tödt2, P Jakobsson3, M Unosson4, E Skargren5, M Kentsson6, K Theander7.   

Abstract

OBJECTIVES: To describe a multidimensional symptom profile in patients with stable chronic obstructive pulmonary disease (COPD) and determine whether symptom experience differed between patients with moderate or severe airflow limitations.
BACKGROUND: Patients with severe airflow limitation experience numerous symptoms, but little is known regarding patients with moderate airflow limitation.
METHODS: A multidimensional symptom profile (Memorial Symptom Assessment Scale) was assessed in 42 outpatients with moderate and 49 with severe airflow limitations.
RESULTS: The mean number of symptoms in the total sample was 7.9 (±4.3) with no difference between patients with moderate and severe airflow limitations. The most prevalent symptoms with the highest MSAS symptom burden scores were shortness of breath, dry mouth, cough, sleep problems, and lack of energy in both groups.
CONCLUSIONS: Patients with moderate or severe airflow limitations experience multiple symptoms with high severity and distress. An assessment of their multidimensional symptom profile might contribute to better symptom management.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Respiratory nursing; Symptom assessment; Symptom experience

Mesh:

Year:  2014        PMID: 24856227     DOI: 10.1016/j.hrtlng.2014.04.004

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  8 in total

Review 1.  Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations.

Authors:  Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden
Journal:  J Natl Cancer Inst       Date:  2017-01-24       Impact factor: 13.506

2.  Effect of symptoms on physical performance in COPD.

Authors:  Jungeun Lee; Huong Q Nguyen; Monica E Jarrett; Pamela H Mitchell; Kenneth C Pike; Vincent S Fan
Journal:  Heart Lung       Date:  2018-02-01       Impact factor: 2.210

3.  Distinct symptom experiences in subgroups of patients with COPD.

Authors:  Vivi L Christensen; Tone Rustøen; Bruce A Cooper; Christine Miaskowski; Anne H Henriksen; Signe B Bentsen; Are M Holm
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-02

4.  Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study.

Authors:  Liwei Cui; Xiuli Ji; Mengshuang Xie; Shuang Dou; Wei Wang; Wei Xiao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-30

5.  Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: a cross-sectional study.

Authors:  Tian Xiao; Hua Qiu; Yue Chen; Xianfeng Zhou; Kang Wu; Xiaonan Ruan; Na Wang; Chaowei Fu
Journal:  BMC Psychiatry       Date:  2018-04-04       Impact factor: 3.630

6.  Psychosocial issues need more attention in COPD self-management education.

Authors:  Hannele Siltanen; Tiina Aine; Heini Huhtala; Marja Kaunonen; Tuula Vasankari; Eija Paavilainen
Journal:  Scand J Prim Health Care       Date:  2020-02-06       Impact factor: 2.581

Review 7.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

8.  Chronic Obstructive Pulmonary Disease Symptom Cluster Composition, Associated Factors, and Methodologies: A Systematic Review.

Authors:  Fei Fei; Jonathan Koffman; Xiaohan Zhang; Wei Gao
Journal:  West J Nurs Res       Date:  2021-03-06       Impact factor: 1.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.